Valion Bio, Inc.
VBIO
$2.44
-$0.06-2.40%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -7.10M | -6.20M | -2.85M | -2.60M | -1.93M |
| Total Depreciation and Amortization | 609.00K | 181.00K | 3.00K | 0.00 | 1.00K |
| Total Amortization of Deferred Charges | 489.00K | 445.00K | -- | -- | -- |
| Total Other Non-Cash Items | 328.00K | 391.00K | 378.00K | 579.00K | 199.00K |
| Change in Net Operating Assets | 396.00K | 174.00K | 84.00K | 21.00K | -96.00K |
| Cash from Operations | -5.28M | -5.01M | -2.29M | -2.00M | -1.83M |
| Capital Expenditure | -57.00K | -7.00K | -25.00K | -10.00K | -3.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -124.00K | 0.00 | -17.00K |
| Cash from Investing | -57.00K | -7.00K | -149.00K | -10.00K | -20.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 69.00K | -- | 0.00 | 429.00K | 1.91M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 241.00K | -- | 11.87M | 3.75M | 585.00K |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -79.00K | -44.00K | -240.00K | 90.00K | -131.00K |
| Cash from Financing | 231.00K | -44.00K | 11.63M | 4.27M | 2.36M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -5.11M | -5.06M | 9.20M | 2.27M | 515.00K |